Cancer develops when a cell accumulates enough genetic damage to start growing without the usual controls, and whether that happens to any particular person depends on an overlapping set of factors: inherited vulnerability, random copying errors in DNA, environmental exposures, immune function, and the body’s varying ability to repair damage before it matters. No single cause explains most cases, and no single protective factor guarantees safety. That tension between controllable and uncontrollable risk is what makes the question so frustrating, and why the honest answer requires pulling apart several threads at once.
The Role of Sheer Randomness
Every time a cell divides, it copies roughly three billion letters of DNA. The copying machinery is remarkably accurate, but not perfect, and over a lifetime, errors pile up. A landmark study found that the lifetime risk of cancer across many tissue types correlates strongly with the total number of stem-cell divisions in that tissue, with a correlation of 0.81. The researchers concluded that about two-thirds of the variation in cancer risk among tissues is attributable to these random replication errors rather than to environmental factors or inherited predispositions.1PubMed Central. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions Tissues whose stem cells divide more frequently, like the colon lining and the blood-forming system, tend to produce cancers more often than tissues with slower turnover, like the brain.
This does not mean cancer is purely a matter of luck. It means that even in a hypothetical world where nobody smoked, nobody carried a harmful gene variant, and nobody was exposed to a single carcinogen, cancer would still occur because DNA replication is inherently imperfect. The “bad luck” framing generated controversy when it was published, partly because it seemed to minimize the importance of prevention. But the researchers were comparing tissues to each other, not arguing that prevention is useless. Smoking, for instance, doesn’t just add random mutations; it adds specific kinds of damage on top of the baseline copying errors, dramatically raising the odds in tissues that are already turning over.
Inherited Genetic Vulnerability
A small proportion of cancers trace back to mutations people are born with. These inherited variants sit in every cell of the body from the start and give certain tissues a head start toward malignancy.2PubMed Central. Mechanisms of inherited cancer susceptibility The most familiar examples involve genes like BRCA1 and BRCA2, where mutations greatly increase the risk of breast and ovarian cancer, along with TP53 and PTEN mutations that predispose carriers to a range of tumor types.3European Journal of Medical and Health Sciences. Gene Mutations in Hereditary Breast Cancer- A Review These are sometimes called high-penetrance variants because a single mutation confers a large increase in risk.
But high-penetrance mutations are rare. Most inherited cancer risk comes from hundreds or even thousands of common genetic variants, each nudging risk up or down by a tiny amount. When researchers combine these small effects into a polygenic risk score, the aggregate can explain a meaningful slice of heritability. For breast cancer, polygenic risk scores built from genome-wide association studies account for over 30 percent of the disease’s heritability.4PubMed Central. Polygenic risk scores and breast cancer risk prediction So two people who lead identical lives and face identical exposures can still carry very different inherited susceptibility, spread across many genes rather than concentrated in one dramatic mutation.
How Well Your Body Fixes Damage
DNA takes hits constantly, from replication errors, from UV light, from metabolic byproducts inside the cell. What prevents most of that damage from becoming cancer is an elaborate repair system that catches mistakes and corrects them before the cell divides again. But the efficiency of that repair system differs from person to person. A large meta-analysis of 55 case-control studies confirmed that people with lower DNA repair capacity have increased susceptibility to cancer, and that finding held across multiple cancer types and multiple laboratory assays used to measure repair.5Scientific Reports. DNA repair phenotype and cancer risk: a systematic review and meta-analysis of 55 case–control studies
The variation is not subtle. When researchers measured how quickly healthy people’s white blood cells repaired oxidative DNA damage, the slowest quarter of participants had an average repair half-life of 81 minutes, while the fastest quarter managed it in 24 minutes, roughly three times faster.6PubMed Central. CometChip analysis of human primary lymphocytes enables quantification of inter-individual differences in the kinetics of repair of oxidative DNA damage If you are someone whose cells are slower to fix everyday damage, you carry a higher baseline risk simply because more errors have a chance to persist through cell division. This variation is partly genetic and partly influenced by age, nutrition, and other environmental factors, which helps explain why risk is so personal even among people who seem to share similar lifestyles.
Environmental Exposures and the Mutations They Leave Behind
Environmental carcinogens do not just raise risk in some abstract statistical sense. They leave specific fingerprints in a tumor’s DNA. Tobacco smoking, for example, is linked to increased mutation burdens carrying multiple distinct mutational signatures. One of those signatures, found predominantly in cancers of tissues directly exposed to smoke like the lungs and larynx, results from the misreplication of DNA damage caused by tobacco carcinogens.7PubMed Central. Mutational signatures associated with tobacco smoking in human cancer These smoking-related mutational processes also generate protein-truncating mutations, the kind that disable tumor-suppressor genes entirely.8PubMed Central. Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes
UV radiation from the sun leaves its own signature in skin cancers. Alcohol damages cells in the mouth, throat, and liver. Asbestos fibers lodge in lung tissue and cause chronic irritation. Each of these exposures adds mutations on top of the random copying errors that are already accumulating, and the more mutations a cell accumulates, the higher the chance that the right combination of driver mutations will arise. Two people with the same inherited genetic background and the same repair capacity can end up with very different cancer trajectories depending on what their cells have been exposed to over decades.
Obesity, Inflammation, and Metabolic Risk
Excess body fat does not just sit inert. Adipose tissue is an active endocrine organ, secreting hormones and signaling molecules that influence how cells grow, divide, and respond to damage. When fat stores expand beyond a certain point, the tissue becomes chronically inflamed, and that inflammation itself promotes tumor development through multiple pathways. Obesity leads to elevated levels of insulin, disrupted blood sugar regulation, and abnormal lipid levels, all of which can fuel tumor growth. Chronic inflammation is a well-known mediator of cancer, and obesity-induced inflammation adds cancer risk beyond what body weight alone would predict.9PubMed. Obesity, Inflammation, and Cancer
This matters for the question of “why me and not them” because two people at different body weights are living in meaningfully different internal environments. The person with more visceral fat has higher circulating insulin, more inflammatory signaling, and a tissue microenvironment that is more hospitable to early cancerous changes. This is one of the clearest examples of how a modifiable risk factor works mechanistically rather than just statistically.
The Immune System as Gatekeeper
Your immune system is constantly patrolling for cells that look abnormal. When it works well, immune cells can identify and destroy nascent tumor cells before they ever form a noticeable mass, a process called immunosurveillance. Animal models and data from human cancer patients strongly support the concept that the immune system can control early-stage tumor cells this way.10PubMed Central. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy People with suppressed immune systems, including organ transplant recipients on immunosuppressive drugs, have substantially higher cancer rates, which gives a clear signal of how much work the immune system is doing in the background.
But the relationship is not one-directional. The immune system can also inadvertently promote tumor progression through chronic inflammation, by selecting for tumor cell variants that are invisible to immune detection, and by suppressing antitumor responses.10PubMed Central. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy In other words, a tumor that survives the initial immune assault may emerge as a harder-to-kill version, shaped by the very defenses that tried to eliminate it. Variation in immune genetics, including the human leukocyte antigen molecules that present tumor fragments to immune cells, adds another layer of individual difference. Research has shown, however, that the relationship between germline immune genetics and outcomes like immunotherapy response is more complicated than early hopes suggested, with HLA genotypes alone not reliably predicting who benefits from treatment.11PubMed Central. Genetic variation in antigen presentation and cancer immunotherapy
Infections That Set the Stage
Roughly one in six cancers worldwide is linked to an infectious agent. Viruses and bacteria can drive cancer by interfering with the cellular machinery that keeps DNA intact, blocks damaged cells from dividing, and triggers programmed cell death. These microorganisms have evolved mechanisms that hamper pathways dedicated to maintaining genetic integrity, which eventually reduces the host’s ability to repair damage and can result in cellular transformation and cancer progression.12PubMed Central. Viruses and Bacteria Associated with Cancer: An Overview
The clearest bacterial example is Helicobacter pylori, which infects the stomach lining and drives chronic inflammation that can lead to gastric cancer. But research increasingly points to other bacteria contributing to tumor development across multiple organ systems, through genotoxic metabolites, disruption of cell-cycle regulation, and modulation of immune responses.13PubMed Central. Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associations On the viral side, human papillomavirus drives most cervical cancers, hepatitis B and C viruses cause liver cancer, and Epstein-Barr virus is linked to certain lymphomas and nasopharyngeal cancers. Whether someone contracts one of these infections, and whether the infection becomes chronic rather than being cleared, is partly a matter of geography, vaccination, sexual behavior, and immune function, adding yet another variable to the question of who gets cancer.
The gut microbiome, the broader community of microorganisms living in the digestive tract, also appears to influence cancer risk in both directions. Certain microbial communities and their metabolites can act as cancer promoters, while others may have protective effects.14PubMed Central. Understanding the role of the gut microbiome in gastrointestinal cancer: A review The composition of your microbiome depends on diet, antibiotic use, geography, and genetics, meaning it is another source of person-to-person variation in cancer susceptibility.
Why Age Is the Single Biggest Risk Factor
Most cancers are diagnosed in people over 60, and the reason extends beyond just having had more time for mutations to accumulate. As people age, cells throughout the body acquire mutations that do not cause cancer on their own but give certain cell lineages a growth advantage. These expanded clones, a phenomenon called somatic mosaicism, are detectable in subpopulations of cells and become increasingly common in adult tissues as people get older.15PubMed Central. The ageing genome, clonal mosaicism and chronic disease In the blood-forming system, this clonal expansion is especially well documented: studies have found that expanded blood cell clones carrying mutations in preleukemic driver genes become a near-universal feature of aging.16PubMed Central. Clonal hematopoiesis, somatic mosaicism, and age-associated disease
So aging does not just give more time for one unlucky mutation to occur. It actively reshapes the genetic landscape of your tissues, creating fields of cells that are already partway toward cancer. At the same time, the immune system weakens with age, DNA repair slows, and chronic low-grade inflammation rises. All of these changes converge to make the older body a more permissive environment for tumor initiation. This is why a 70-year-old and a 25-year-old carrying the same inherited mutations can have very different cancer timelines.
Epigenetic Changes and the Tissue Neighborhood
Not all cancer-relevant changes involve altering the DNA sequence itself. Epigenetic modifications, chemical tags on DNA and its associated proteins that control which genes are active, can drift out of their normal patterns and mimic some of the effects of mutations. Researchers studying cervical tissue found that dysregulation of age- and cancer-associated epigenetic patterns was apparent even at the earliest precancerous stages, with the majority of features observed in advanced precancerous lesions overlapping with those seen in fully developed cervical cancer.17Communications Medicine. Functionally enriched epigenetic clocks reveal tissue-specific discordant aging patterns in individuals with cancer This suggests that the epigenetic landscape of a tissue can shift toward cancer long before a traditional mutation-based diagnosis would pick anything up.
The neighborhood around a potential tumor cell matters too. Cancer is increasingly understood not just as a disease of a single rogue cell but as a disease of the tissue environment that cell lives in. The tumor microenvironment, including immune cells, blood vessels, connective tissue, and signaling molecules, plays an active role in whether an early cancerous cell thrives or dies.18PubMed Central. Role of tumor microenvironment in cancer progression and therapeutic strategy Two people with identical mutations in a given tissue can have different outcomes depending on the local inflammation, oxygen supply, and immune cell population surrounding those mutated cells.
Stress, Sleep, and Circadian Disruption
Chronic psychological stress activates the sympathetic nervous system and the hormonal stress axis, both of which can promote tumor development and progression through effects on immune function, inflammation, and the tumor microenvironment.19PubMed Central. Effect of chronic stress on tumorigenesis and development This does not mean that having a stressful year will give you cancer, but sustained, unrelenting stress over years can shift the body’s internal environment in ways that favor tumor growth. The stress hormones cortisol and norepinephrine influence how immune cells behave, how blood vessels grow around tumors, and how easily cancer cells spread.
Circadian disruption, from chronic shift work, jet lag, or simply irregular sleep patterns, represents another underappreciated factor. Circadian genes regulate cell division and programmed cell death; when those genes are chronically out of sync, cells can proliferate abnormally. Moreover, circadian rhythms coordinate DNA repair, and disrupting them leads to accumulated DNA damage, a precursor to cancer.20Journal of the National Cancer Center. The multifaceted impact of circadian disruption on cancer risk: a systematic review of insights and economic implications The International Agency for Research on Cancer has classified night shift work as a probable carcinogen, reflecting the strength of this association. For the question of why one person gets cancer and another doesn’t, this means that invisible lifestyle patterns like sleep quality and work schedules can quietly tilt the odds.
What Starts Before Birth
Some cancer risk appears to be set before a person is even born. Research on breast cancer suggests that the hormonal environment in the womb can modify the fetal epigenome in ways that persist for life. Maternal diet and exposure to endocrine-active environmental chemicals can alter how mammary gland tissue develops, potentially increasing the vulnerability of breast tissue to later-life cancer triggers.21PubMed. Fetal origins of breast cancer These epigenetic modifications are inherited by daughter cells during development and maintained throughout life, meaning a person’s cancer susceptibility can be partly shaped by conditions they never experienced consciously. This is a humbling addition to the picture: even among adults making identical lifestyle choices, differences laid down decades earlier in the uterine environment could be contributing to their divergent outcomes.
What Other Species Reveal
If cancer were simply a function of having more cells that can go wrong, you would expect elephants and whales to get cancer far more often than mice. They don’t. Animals with a thousand times more cells than humans do not show an increased cancer rate, a puzzle known as Peto’s paradox that suggests natural selection has equipped large, long-lived species with extra layers of cancer suppression.22PubMed Central. Peto’s Paradox: evolution’s prescription for cancer prevention Elephants, for example, carry extra copies of the TP53 tumor-suppressor gene. Blind mole rats have an entirely different strategy: their cells undergo massive necrotic death when they start to overproliferate, a mechanism mediated by the p53 and Rb pathways and triggered by the release of an immune signaling molecule called interferon-beta. This is distinct from the approach used by naked mole rats, whose cells are hypersensitive to contact inhibition and simply stop growing when they touch neighboring cells.23PubMed Central. Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism
Humans have their own anti-cancer defenses, but they are the product of evolutionary trade-offs. The theory of antagonistic pleiotropy proposes that genes beneficial for reproduction early in life can have harmful effects later, including promoting aging and cancer susceptibility.24Mechanisms of Ageing and Development. Antagonistic pleiotropy and p53 In evolutionary terms, a gene that helps you survive to reproduce is favored even if it raises your cancer risk at 70, because natural selection cares more about the first few decades of life than the last. This means that some of the biological machinery that makes humans prone to cancer is deeply embedded in our evolutionary heritage, not easily eliminated by any lifestyle change.
Exercise and the Limits of Personal Control
Physical activity is one of the best-documented modifiable factors for reducing cancer incidence. Exercise reduces cancer risk and has been shown to inhibit tumor growth through direct effects on tumor biology, broader systemic effects on metabolism and immune function, and improvements in the efficacy of cancer treatment.25Cell Metabolism / Elsevier. Molecular Mechanisms Linking Exercise to Cancer Prevention and Treatment Regular physical activity reduces inflammation, improves insulin sensitivity, and enhances immune surveillance, effectively pushing back against several of the mechanisms described above.
But exercise, like every other modifiable factor, operates within the constraints of someone’s inherited genetics, accumulated mutations, immune function, and exposures. A lifelong runner who carries a BRCA1 mutation still faces elevated breast cancer risk. A person who never smoked can still develop lung cancer from random replication errors or radon exposure. The uncomfortable truth underlying the entire question is that cancer risk is a composite of dozens of overlapping factors, some under your control and many not. Prevention matters enormously at the population level, where reducing smoking, increasing vaccination, maintaining a healthy weight, and staying physically active saves millions of lives. At the individual level, though, doing everything right reduces risk without eliminating it, and doing everything wrong does not guarantee cancer either. The gap between population-level statistics and personal fate is where the question “why me?” lives, and it remains one of the most difficult things to accept about the biology of this disease.